| Mr Harry William Conrad Oberg Iii, RPH | |
|
524 Front St, Evanston, WY 82930-3577 | |
| (307) 789-3494 | |
| (307) 789-5554 |
| Full Name | Mr Harry William Conrad Oberg Iii |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 524 Front St, Evanston, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760533137 | NPI | - | NPPES |
| 2074 | Other | WY | PHARMACIST CERTIFICATE NO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2074 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Harry William Conrad Oberg Iii, RPH 13643 State Highway 150 S, Po Box 427, Evanston, WY 82930-9752 Ph: (307) 789-9876 | Mr Harry William Conrad Oberg Iii, RPH 524 Front St, Evanston, WY 82930-3577 Ph: (307) 789-3494 |
News Archive
A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse.
In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington's disease.
UCSF scientists have discovered a new stem cell in the developing human brain. The cell produces nerve cells that help form the neocortex - the site of higher cognitive function - and likely accounts for the dramatic expansion of the region in the lineages that lead to man, the researchers say.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and Proteros Biostructures announced today that they have been awarded a grant by the German Federal Ministry of Education and Research, BMBF. The funding of approximately EUR 850,000 supports both companies in establishing a new technology platform for efficient structural characterization of antibody-antigen-complexes.
Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.
› Verified 1 days ago
Deanna Duryea Parkin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 70 Yellow Creek Rd, Evanston, WY 82930 Phone: 307-789-0535 Fax: 307-789-9550 | |
James Allen Poppe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 70 Yellow Creek Rd, Evanston, WY 82930 Phone: 307-789-0535 Fax: 307-789-9550 | |
Katrina Roberts, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 70 Yellow Creek Rd, Evanston, WY 82930 Phone: 307-789-0535 | |
Dr. Jennifer Mary Arroyo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 831 Highway 150 S, Evanston, WY 82930 Phone: 307-789-3464 | |
Courtney Cleckler, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N 2nd St, Evanston, WY 82930 Phone: 307-789-0020 | |
Andrew Cannon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 10th St, Evanston, WY 82930 Phone: 208-390-9107 | |
Dr. Zachary Fitch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 10th St, Evanston, WY 82930 Phone: 307-789-4000 |